Prelude Capital Management’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $195K | Sell |
13,886
-19,881
| -59% | -$268K | 0.01% | 923 |
|
|
2025
Q4 | $379K | Buy |
33,767
+13,030
| +63% | +$149K | 0.03% | 668 |
|
|
2025
Q3 | $240K | Sell |
20,737
-3,947
| -16% | -$46.2K | 0.02% | 848 |
|
|
2025
Q2 | $302K | Buy |
24,684
+3,984
| +19% | +$50.1K | 0.03% | 610 |
|
|
2025
Q1 | $297K | Buy |
20,700
+8,241
| +66% | +$129K | 0.03% | 715 |
|
|
2024
Q4 | $198K | Buy |
+12,459
| New | +$247K | 0.02% | 1000 |
|
|
2024
Q1 | – | Sell |
-14,593
| Closed | -$327K | – | 1323 |
|
|
2023
Q4 | $327K | Buy |
14,593
+4,431
| +44% | +$91.5K | 0.03% | 699 |
|
|
2023
Q3 | $205K | Buy |
+10,162
| New | +$230K | 0.02% | 888 |
|
|
2020
Q4 | – | Sell |
-2,320
| Closed | -$77K | – | 1319 |
|
|
2020
Q3 | $77K | Sell |
2,320
-900
| -28% | -$28.8K | 0.01% | 995 |
|
|
2020
Q2 | $95K | Buy |
3,220
+20
| +0.6% | +$579 | 0.02% | 971 |
|
|
2020
Q1 | $86K | Buy |
+3,200
| New | +$95.6K | 0.02% | 635 |
|
|
2019
Q1 | – | Sell |
-7,042
| Closed | -$315K | – | 1758 |
|
|
2018
Q4 | $315K | Buy |
7,042
+1,793
| +34% | +$93.9K | 0.03% | 594 |
|
|
2018
Q3 | $360K | Buy |
+5,249
| New | +$338K | 0.03% | 620 |
|
|
2016
Q4 | – | Sell |
-14,699
| Closed | -$509K | – | 1540 |
|
|
2016
Q3 | $509K | Buy |
14,699
+5,547
| +61% | +$194K | 0.07% | 310 |
|
|
2016
Q2 | $298K | Buy |
9,152
+2,352
| +35% | +$72K | 0.05% | 394 |
|
|
2016
Q1 | $195K | Buy |
6,800
+4,100
| +152% | +$109K | 0.03% | 561 |
|
|
2015
Q4 | $90K | Buy |
+2,700
| New | +$84K | 0.02% | 846 |
|
|
2015
Q3 | – | Sell |
-1,000
| Closed | -$41K | – | 1475 |
|
|
2015
Q2 | $41K | Buy |
+1,000
| New | +$44.9K | 0.01% | 1214 |
|
Other funds holding AVNS
AC
VCM
VPM
